Very nice and Cozy, The staff was very professional and knowledgeable Response from the owner: Jerry, thank you so much
You may add additional vials from the same lot/batch for variation testing
Romariz and colleagues show that GLP-1 agonists decrease body weight, body mass index (BMI), and waist circumference in children aged 619 with obesity
With Savings Programmes Commercial insurance (both drugs): savings cards can reduce cost to as little as $25 per month Zepbound vials via LillyDirect: single-dose vials (self-drawn with a syringe) are significantly cheaper than pens Wegovy via NovoCare cash pricing: roughly $199$349 per month for uninsured/underinsured patients Insured but no weight-loss coverage: Zepbound may still cost ~$550/month through Lillys programme Important 2026 Cost News Oral Wegovy launched January 2026 a daily tablet at $149$299/month cash, a meaningful option for those who dislike injections Novo Nordisk announced a Wegovy list-price cut to ~$675/month from January 2027 (roughly 50% reduction) Foundayo (orforglipron) launched April 2026 the first oral GLP-1 with no food or water restrictions, ~$25/month with insurance
Common side effects of liraglutide are mainly gastrointestinal, and can include nausea, vomiting, constipation, or indigestion
Compared with exenatide, lixisenatide is generally well tolerated, with a lower incidence of hypoglycemia, lower immune response at the injection site, and less side effects such as nausea and vomiting